Health gains of smoking cessation: accounting for age and time since smoking cessation

Size: px
Start display at page:

Download "Health gains of smoking cessation: accounting for age and time since smoking cessation"

Transcription

1 Health gains of smoking cessation: accounting for age and time since smoking cessation Rudolf Hoogenveen, Pieter van Baal 2006 may 22

2 Contents Background Methodology - Introduction of RIVM Chronic Disease Model - Application of CDM on smoking Data used Analyses and results Conclusions and discussion

3 Background

4 Background - Quantifying the potential effects of tobacco control on burden of disease is useful to support policy makers in setting priorities - However, a problem emerges when trying to estimate possible health gains of smoking cessation: relapse rates, disease risks and thus health gains not only depend on age, but also on time since smoking cessation - Solution: introducing time since cessation next to age in simulation model

5 Methodology Introduction of RIVM Chronic Disease Model (CDM) as starting simulation model for quantifying the effects Application of CDM on smoking

6 RIVM Chronic Disease Model (CDM) CDM is a multi-state Markov-type simulation model to describe the changes of morbidity and mortality from severa chronic diseases resulting from changes of several risk factor in the Dutch population Methodology: - Life course of cohorts are modeled - Model states are defined by risk factor class and by disease state - Change of state prevalence rates are modeled through transitions between states (state-transition, Markov-type) - Disease incidence rates depend on risk factor levels - Mortality rates depend on disease status - All transition rates are specified by gender and age

7 State-transition structure of CDM Transitions between risk factor classes class 1 class 2 class n class transition rates mortality rates mortality Transitions between disease states without disease with disease mortality from other causes of death mortality from disease mortality

8 Application of CDM on smoking That means: - selection of risk factor smoking and all smoking-related diseases - standard CDM version: smoking cessation and disease incidence rates dependent on age - new CDM version: rates dependent on time since smoking cessation

9 Model structure: In case of age-dependent rates: start stop never current former relapse rates depend on age In case of time-dependent rates: continuously stops start stop never current former <1 year former >1 year <2 year former >20 year relapse rates depend on time since smoking cessation

10 Data used

11 Data on smoking behaviour from retrospective survey - initial distribution over never/current/former smoking classes - age-dependent start, stop and relapse rates - relapse rates dependent on time since smoking cessation Disease data from registries in general practice and cancer registries - disease-related excess mortality rates (DisMod) Relative risks from literature - relative risks for disease incidence dependent on age dependent on time since smoking cessation Disability weights from Dutch Burden of Disease Study - disabiliy weights specified by disease to quality-adjust life years

12 Analyses and results

13 Two scenarios on 50 years old current smokers: - (1) current practice - (2) all current smokers quit at start of simulation period Two models: relapse rates and disease incidence rates that depend on - (1) age - (2) time since smoking cessation Results: effects of smoking cessation on: - (1) life years gained - (2) smoking prevalence numbers - (3) disease incidence numbers

14 Life years gained for any quitter dependency model age time total 1,2 2,0 quality-adjusted smoking-related diseases only 1,4 2,5 all diseases (# 71) 1,2 2,0

15 Former smoking prevalence numbers and rates delta former smokers number age time time delta former smokers proportion 0,4 0,35 0,3 0,25 0,2 0,15 0,1 0, time age time

16 Current and cumulative incidence numbers of acute myocardial infarction (AMI) delta AMI incidence number age time -100 time delta cumulative AMI incidence number age time time

17 Conclusions and discussion

18 Not taking into account smoking cessation time results in biased effec measures of interventions Results from simulation models can be sensitive to assumptions regarding the model structure, i.e. transition rates for former smoker that depend on age or on time since cessation Sensitivity results are not uniform, e.g. they depend on the outcome variable and time horizon chosen More complex models require more detailed data, e.g. relative risks used for second model were specified by age and by time since smoking cessation

19 Colleagues involved with this CDM application RIVM PZO RIVM VTV RIVM IMA StiVoRo P van Baal, T Feenstra, R Hoogenveen N Hoeijmans, H Boshuizen, M Willemsen,

Cost-effectiveness analyses of health promotion programs: a case study of smoking prevention and cessation among Dutch students

Cost-effectiveness analyses of health promotion programs: a case study of smoking prevention and cessation among Dutch students HEALTH EDUCATION RESEARCH Vol.23 no.2 2008 Pages 310 318 Advance Access publication 4 August 2007 Cost-effectiveness analyses of health promotion programs: a case study of smoking prevention and cessation

More information

The potential impact of smoking interventions on HLY in France. W. Nusselder, D. Wapperom, C. Looman, H. Boshuizen for JA EHLEIS

The potential impact of smoking interventions on HLY in France. W. Nusselder, D. Wapperom, C. Looman, H. Boshuizen for JA EHLEIS The potential impact of smoking interventions on HLY in France W. Nusselder, D. Wapperom, C. Looman, H. Boshuizen for JA EHLEIS REVES, Edinburgh 28-30 May 2014 Background and aim Tobacco is leading cause

More information

Project Report. Economic model of adult smoking related costs and consequences for England. October 2010 Revised: April 2011

Project Report. Economic model of adult smoking related costs and consequences for England. October 2010 Revised: April 2011 Project Report Economic model of adult smoking related costs and consequences for England October 2010 Revised: April 2011 Christine Godfrey, Shehzad Ali, Steve Parrott, Kate Pickett Department of Health

More information

Quantitative health impact assessment in Copenhagen

Quantitative health impact assessment in Copenhagen Quantitative health impact assessment in Copenhagen - an application of the DYNAMO-HIA model Astrid Ledgaard Holm Henrik Brønnum-Hansen University of Copenhagen Department of Public Health Section of Social

More information

Predicting the population health effects of changing tobacco exposures: Statistical models for regulatory compliance

Predicting the population health effects of changing tobacco exposures: Statistical models for regulatory compliance Predicting the population health effects of changing tobacco exposures: Statistical models for regulatory compliance NASEM ENDS Workshop February 2017 Annette M. Bachand, Ph.D. Goal of Statistical Models:

More information

Annette M. Bachand, 1, Sandra I. Sulsky, 1 and Geoffrey M. Curtin 2

Annette M. Bachand, 1, Sandra I. Sulsky, 1 and Geoffrey M. Curtin 2 Risk Analysis, Vol. 38, No. 1, 2018 DOI: 10.1111/risa.12819 Assessing the Likelihood and Magnitude of a Population Health Benefit Following the Market Introduction of a Modified-Risk Tobacco Product: Enhancements

More information

The cost-effectiveness of raising the legal smoking age in California Ahmad S

The cost-effectiveness of raising the legal smoking age in California Ahmad S The cost-effectiveness of raising the legal smoking age in California Ahmad S Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each

More information

A complex evaluation of a complex system: Evaluating the smoking cessation system of a Public Health Unit to guide policy change

A complex evaluation of a complex system: Evaluating the smoking cessation system of a Public Health Unit to guide policy change A complex evaluation of a complex system: Evaluating the smoking cessation system of a Public Health Unit to guide policy change Nadia Minian; Robert Schwartz; John Garcia; Roshan Guna. Background Reducing

More information

Effects of smoking and smoking cessation on productivity in China

Effects of smoking and smoking cessation on productivity in China Effects of smoking and smoking cessation on productivity in China Team *Hong Wang; MD, PhD **Heng-Fu Zou; PhD I. Introduction *: Yale University; **: World Bank 1. Aim of Project We will study smoking

More information

Cost-effectiveness of a mass media campaign and a point of sale intervention to prevent the uptake of smoking in children and young people:

Cost-effectiveness of a mass media campaign and a point of sale intervention to prevent the uptake of smoking in children and young people: Cost-effectiveness of a mass media campaign and a point of sale intervention to prevent the uptake of smoking in children and young people: Economic modelling report M. Raikou, A. McGuire LSE Health, London

More information

Comprehensive Tobacco Control Programs: Economic Review. Page 1 of 26. Study Info Intervention Characteristics Population Characteristics

Comprehensive Tobacco Control Programs: Economic Review. Page 1 of 26. Study Info Intervention Characteristics Population Characteristics Study Info Intervention Characteristics Population Characteristics Author, Year: Carter, 2000 Study design: Cost-effectiveness analysis Perspective: Commonwealth and Healthcare sector Location: Australia

More information

Using the Stages of Change Model to Choose an Optimal Health Marketing Target

Using the Stages of Change Model to Choose an Optimal Health Marketing Target UW Biostatistics Working Paper Series 3-16-2010 Using the Stages of Change Model to Choose an Optimal Health Marketing Target Paula Diehr University of Washington, pdiehr@u.washington.edu Peggy A. Hannon

More information

Varenicline and cardiovascular and neuropsychiatric events: Do Benefits outweigh risks?

Varenicline and cardiovascular and neuropsychiatric events: Do Benefits outweigh risks? Varenicline and cardiovascular and neuropsychiatric events: Do Benefits outweigh risks? Sonal Singh M.D., M.P.H, Johns Hopkins University Presented by: Sonal Singh, MD MPH September 19, 2012 1 CONFLICTS

More information

Psychosis & Schizophrenia: The Updated NICE Quality Standard. Dr Tony Gill Mental Health Practitioner University of Leeds 7 th June 2015

Psychosis & Schizophrenia: The Updated NICE Quality Standard. Dr Tony Gill Mental Health Practitioner University of Leeds 7 th June 2015 Psychosis & Schizophrenia: The Updated NICE Quality Standard Dr Tony Gill Mental Health Practitioner University of Leeds 7 th June 2015 NICE.what is it? The National Institute for Health & Care Excellence

More information

Cost-effectiveness of brief intervention and referral for smoking cessation

Cost-effectiveness of brief intervention and referral for smoking cessation Cost-effectiveness of brief intervention and referral for smoking cessation Revised Draft 20 th January 2006. Steve Parrott Christine Godfrey Paul Kind Centre for Health Economics on behalf of PHRC 1 Contents

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Clair C, Rigotti NA, Porneala B, et al. Association of smoking cessation and weight change with cardiovascular disease among people with and without diabetes. JAMA. doi:10.1001/jama.2013.1644.

More information

Reducing Tobacco Use and Secondhand Smoke Exposure: Smoke-Free Policies

Reducing Tobacco Use and Secondhand Smoke Exposure: Smoke-Free Policies Reducing Tobacco Use and Secondhand Smoke Exposure: Smoke-Free Policies Summary Evidence Table Evidence Location Costs Benefits American Cancer Society (ACS) 2011 United States 27 states without current

More information

Potential impacts of tobacco tax on health, health inequalities, and health system costs?

Potential impacts of tobacco tax on health, health inequalities, and health system costs? 1 Potential impacts of tobacco tax on health, health inequalities, and health system costs? Epidemiological and economic modelling in NZ BODE 3 Team (tobacco): Tony Blakely, Linda Cobiac, Amber Pearson,

More information

Cost-effectiveness of smoking cessation in Australia with varenicline, a novel pharmacotherapy

Cost-effectiveness of smoking cessation in Australia with varenicline, a novel pharmacotherapy Cost-effectiveness of smoking cessation in Australia with varenicline, a novel pharmacotherapy Alissa Brown 1, Kate Webb 1, Hansoo Kim 1, Danny Liew 2 1 Pfizer Australia Pty Ltd 2 St Vincent s Hospital,

More information

Proceedings of the 2014 Winter Simulation Conference A. Tolk, S. Y. Diallo, I. O. Ryzhov, L. Yilmaz, S. Buckley, and J. A. Miller, eds.

Proceedings of the 2014 Winter Simulation Conference A. Tolk, S. Y. Diallo, I. O. Ryzhov, L. Yilmaz, S. Buckley, and J. A. Miller, eds. Proceedings of the 2014 Winter Simulation Conference A. Tolk, S. Y. Diallo, I. O. Ryzhov, L. Yilmaz, S. Buckley, and J. A. Miller, eds. A DISCRETE EVENT SIMULATION MODEL TO ESTIMATE POPULATION LEVEL HEALTH

More information

The cost utility of bupropion in smoking cessation health programs: simulation model results for Sweden Bolin K, Lindgren B, Willers S

The cost utility of bupropion in smoking cessation health programs: simulation model results for Sweden Bolin K, Lindgren B, Willers S The cost utility of bupropion in smoking cessation health programs: simulation model results for Sweden Bolin K, Lindgren B, Willers S Record Status This is a critical abstract of an economic evaluation

More information

Present value cost-savings to Medicaid over 25 years

Present value cost-savings to Medicaid over 25 years cost-savings from switching would be realized 2 relies on assumptions about the fraction of aggregate medical expenditures avoided and the rate at which they are realized over a 25-year period. In particular,

More information

Smoking Cessation at Bladder Cancer Diagnosis: Many Patients Might Benefit from this Teachable Moment

Smoking Cessation at Bladder Cancer Diagnosis: Many Patients Might Benefit from this Teachable Moment Smoking Cessation at Bladder Cancer Diagnosis: Many Patients Might Benefit from this Teachable Moment Josemanuel Saucedo, BS Jeffrey Bassett, MD, MPH Lorna Kwan, MPH Sarah E. Connor, MPH, CHES William

More information

Simulation-Based Estimates of Effectiveness and Cost- Effectiveness of Smoking Cessation in Patients with Chronic Obstructive Pulmonary Disease

Simulation-Based Estimates of Effectiveness and Cost- Effectiveness of Smoking Cessation in Patients with Chronic Obstructive Pulmonary Disease Simulation-Based Estimates of Effectiveness and Cost- Effectiveness of Smoking Cessation in Patients with Chronic Obstructive Pulmonary Disease Kokuvi Atsou 1,2, Christos Chouaid 1,2,3, Gilles Hejblum

More information

Tobacco use during adolescence may predict smoking during adulthood: simulation-based research

Tobacco use during adolescence may predict smoking during adulthood: simulation-based research Original article Arch Argent Pediatr 2015;113(2):106-113 / 106 Tobacco use during adolescence may predict smoking during adulthood: simulation-based research Raúl A. Borracci, M.D. a and Andrés H. Mulassi,

More information

The Netherlands SimSmoke: The Effect of Tobacco Control Policies. On Smoking Prevalence and Tobacco Attributable Deaths in the Netherlands

The Netherlands SimSmoke: The Effect of Tobacco Control Policies. On Smoking Prevalence and Tobacco Attributable Deaths in the Netherlands The Netherlands SimSmoke: The Effect of Tobacco Control Policies On Smoking Prevalence and Tobacco Attributable Deaths in the Netherlands Submitted by David Levy Pacific Institute for Research and Evaluation

More information

DYNAMO-HIA modelling obesity outcomes. Wilma Nusselder Erasmus MC, The Netherlands

DYNAMO-HIA modelling obesity outcomes. Wilma Nusselder Erasmus MC, The Netherlands DYNAMO-HIA modelling obesity outcomes Wilma Nusselder Erasmus MC, The Netherlands Spotlight meeting The future of research on obesogenic environments, Brussels, November 19th 2015 DYNAMO-HIA DYNAMO-HIA

More information

The Evidence on E-cigarettes: Evaluating What We Have and Identifying What We Need

The Evidence on E-cigarettes: Evaluating What We Have and Identifying What We Need The Evidence on E-cigarettes: Evaluating What We Have and Identifying What We Need Ken Warner University of Michigan School of Public Health U.S. E-cigarette Summit, Washington, DC, May 8, 2017 Conflicts

More information

Associate Professor Gerry Devlin

Associate Professor Gerry Devlin Associate Professor Gerry Devlin Clinical Cardiologist and Interventional Cardiologist NZ Heart Foundation Hamilton 9:00-9:15 Secondary Prevention of IHD The Challenge of Secondary Prevention Associate

More information

Modelling health outcomes of prevention measures for NRW: potential health gains due to reduced obesity and overweight

Modelling health outcomes of prevention measures for NRW: potential health gains due to reduced obesity and overweight Internat. HIA Conference 2-4 Oct, Geneva Modelling health outcomes of prevention measures for NRW: potential health gains due to reduced obesity and overweight Odile Mekel Jutta Grohmann Claudia Terschüren

More information

Economic Analysis of Interventions for Smoking Cessation Aimed at Pregnant Women

Economic Analysis of Interventions for Smoking Cessation Aimed at Pregnant Women Y O R K Health Economics C O N S O R T I U M NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE Economic Analysis of Interventions for Smoking Cessation Aimed at Pregnant Women Supplementary Report

More information

The Sesim-LEV model. Lisa Brouwers Pontus Johansson Karin Mossler Nils Janlöv Anders Ekholm. Ministry of Health and Social Affairs

The Sesim-LEV model. Lisa Brouwers Pontus Johansson Karin Mossler Nils Janlöv Anders Ekholm. Ministry of Health and Social Affairs The Sesim-LEV model Lisa Brouwers Pontus Johansson Karin Mossler Nils Janlöv Anders Ekholm Ministry of Health and Social Affairs Outline Project aims Model Data Health in SESIM-LEV Results Impact Most

More information

the cost-effectiveness of smoking cessation support delivered

the cost-effectiveness of smoking cessation support delivered Eur J Health Econ (2013) 14:789 797 DOI 10.1007/s10198-012-0424-5 ORIGINAL PAPER The cost-effectiveness of smoking cessation support delivered by mobile phone text messaging: Txt2stop Carla Guerriero John

More information

ModelHealth TM : Tobacco

ModelHealth TM : Tobacco HealthPartners Institute for Education and Research ModelHealth TM : Tobacco Technical documentation May 2015 Contents Executive summary... 3 Introduction... 3 Community Guide recommendations... 6 State

More information

the high CVD risk smoker

the high CVD risk smoker Smoking Cessation: population and patients A comprehensive approach to the smoker the high CVD risk smoker Catriona Jennings Cardiovascular Specialist Research Nurse Imperial College London European Society

More information

CORONARY ARTERY DISEASE (CAD) MEASURES GROUP OVERVIEW

CORONARY ARTERY DISEASE (CAD) MEASURES GROUP OVERVIEW CONARY ARTERY DISEASE (CAD) MEASURES GROUP OVERVIEW 2014 PQRS OPTIONS F MEASURES GROUPS: 2014 PQRS MEASURES IN CONARY ARTERY DISEASE (CAD) MEASURES GROUP: #6. Coronary Artery Disease (CAD): Antiplatelet

More information

Non communicable Diseases in Egypt and North Africa

Non communicable Diseases in Egypt and North Africa Non communicable Diseases in Egypt and North Africa Diaa Marzouk Prof. Community Medicine Faculty of Medicine, Ain Shams University Egypt 11 th March 2012 Level of Income North African countries according

More information

Physicians for a Smoke-Free Canada. A look at young adults and smoking Findings from the Canadian Tobacco Use Monitoring Survey

Physicians for a Smoke-Free Canada. A look at young adults and smoking Findings from the Canadian Tobacco Use Monitoring Survey Fact Sheet Physicians for a Smoke-Free Canada A look at young adults and smoking Findings from the Canadian Tobacco Use Monitoring Survey The Canadian Tobacco Use Monitoring Survey is conducted annually

More information

Groupe d Analyse Économique An Analysis Group Company

Groupe d Analyse Économique An Analysis Group Company Groupe d Analyse Économique To: From: Canadian Council for Tobacco Control Groupe d Analyse Économique Date: April 9, 2002 Re: Impact of an anti-tobacco campaign on direct health care costs in Canada 1.

More information

Menthol Cigarettes, Smoking Cessation, Atherosclerosis and Pulmonary Function

Menthol Cigarettes, Smoking Cessation, Atherosclerosis and Pulmonary Function Center for Regulatory Effectiveness (CRE) assessment of the following research report: Menthol Cigarettes, Smoking Cessation, Atherosclerosis and Pulmonary Function By: Mark J. Pletcher, MD, MPH; Benjamin

More information

Cost-effectiveness of evolocumab (Repatha ) for hypercholesterolemia

Cost-effectiveness of evolocumab (Repatha ) for hypercholesterolemia Cost-effectiveness of evolocumab (Repatha ) for hypercholesterolemia The NCPE has issued a recommendation regarding the cost-effectiveness of evolocumab (Repatha ). Following NCPE assessment of the applicant

More information

A New Standard of Care: Smoking Cessation Re-engagement Presentation by: Dr. Colleen Webster & Vince Martin, M.S.W.

A New Standard of Care: Smoking Cessation Re-engagement Presentation by: Dr. Colleen Webster & Vince Martin, M.S.W. Kingston Family Health Team A New Standard of Care: Smoking Cessation Re-engagement - 2015 Presentation by: Dr. Colleen Webster & Vince Martin, M.S.W. Participating Family Health Teams Kingston Family

More information

Modeling of E-cigarette Use. David Levy, PhD Georgetown University

Modeling of E-cigarette Use. David Levy, PhD Georgetown University Modeling of E-cigarette Use David Levy, PhD Georgetown University No Conflicts of Interest Funding has been received for this work from NIDA (NIH) under grant R01DA036497, NCI CISNET U01CA199284, and the

More information

1. Comparative effectiveness of liraglutide

1. Comparative effectiveness of liraglutide Cost-effectiveness of liraglutide (Victoza ) for the treatment of adults with insufficiently controlled type 2 diabetes as an adjunct to diet and exercise. The NCPE has issued a recommendation regarding

More information

Measure #114: Preventive Care and Screening: Inquiry Regarding Tobacco Use

Measure #114: Preventive Care and Screening: Inquiry Regarding Tobacco Use Measure #114: Preventive Care and Screening: Inquiry Regarding Tobacco Use 2010 PQRI REPTING OPTIONS F INDIVIDUAL MEASURES: CLAIMS, REGISTRY DESCRIPTION: Percentage of patients aged 18 years or older who

More information

Tobacco Surveillance and Evaluation: An Update

Tobacco Surveillance and Evaluation: An Update Tobacco Surveillance and Evaluation: An Update Gary A. Giovino, PhD, MS University at Buffalo School of Public Health and Health Professions Overview! Conceptual models of surveillance/evaluation! Relevant

More information

Stage Based Interventions for Tobacco Cessation

Stage Based Interventions for Tobacco Cessation Precontemplation Stage Based Interventions for Tobacco Cessation Relapse Contemplation Preparation Action Maintenance Theoretical and practical considerations related to Movement through the Stages of

More information

ADENIYI MOFOLUWAKE MPH APPLIED EPIDEMIOLOGY WEEK 5 CASE STUDY ASSIGNMENT APRIL

ADENIYI MOFOLUWAKE MPH APPLIED EPIDEMIOLOGY WEEK 5 CASE STUDY ASSIGNMENT APRIL ADENIYI MOFOLUWAKE MPH 510 - APPLIED EPIDEMIOLOGY WEEK 5 CASE STUDY ASSIGNMENT APRIL 4 2013 Question 1: What makes the first study a case-control study? The first case study is a case-control study because

More information

Ahmad Khosravi, Mohammad Ali Mansournia, Mahmood Mahmoodi, Ali Akbar Pouyan 1, Kourosh Holakouie Naieni

Ahmad Khosravi, Mohammad Ali Mansournia, Mahmood Mahmoodi, Ali Akbar Pouyan 1, Kourosh Holakouie Naieni International Journal of Preventive Medicine Original Article Open Access Estimating the Transitional Probabilities of Smoking Stages with Cross sectional Data and 10 Year Projection for Smoking Behavior

More information

Massachusetts Department of Public Health, Tobacco Cessation and Prevention Program. Massachusetts spends $4.3 billion on

Massachusetts Department of Public Health, Tobacco Cessation and Prevention Program. Massachusetts spends $4.3 billion on Massachusetts Tobacco Cessation and Prevention Program Winnable Battles Initiative June 6-8 Massachusetts Department of Public Health, Tobacco Cessation and Prevention Program Context Massachusetts spends

More information

Technical Appendix I26,I27.1,I28,I43-45,I47.0- I47.1,I47.9,I48,I ,I51.0- I51.4,I52,I77-I84,I86-I97,I98.1-I98.8,I99

Technical Appendix I26,I27.1,I28,I43-45,I47.0- I47.1,I47.9,I48,I ,I51.0- I51.4,I52,I77-I84,I86-I97,I98.1-I98.8,I99 Technical Appendix Methods Multi-state life tables were used to determine remaining Health-adjusted life expectancy (HALE) 1,2 of Australian adults aged 35 to 80 years of age in the year 2000 divided amongst

More information

10/27/15. Presenter Disclosures. Objec4ve. Winston Liao. 143 rd Annual APHA. Winston Liao. No relationships to disclose

10/27/15. Presenter Disclosures. Objec4ve. Winston Liao. 143 rd Annual APHA. Winston Liao. No relationships to disclose Winston Liao 143 rd Annual APHA November 3, 2015 Presenter Disclosures Winston Liao No relationships to disclose Objec4ve Ø Describe the public health burden of COPD from a data perspective Present epidemiologic

More information

Figure 1 Modelling of diseases in PRIMEtime (after Barendregt et al. [7])

Figure 1 Modelling of diseases in PRIMEtime (after Barendregt et al. [7]) PRIMEtime PRIMEtime is a new model that combines elements of the PRIME model [1], which estimates the effect of population-level changes in diet, physical activity, and alcohol and tobacco consumption

More information

Study population The study population comprised type 1 and 2 diabetic patients without renal complications.

Study population The study population comprised type 1 and 2 diabetic patients without renal complications. Diabetes nephropathy in the Netherlands: a cost effectiveness analysis of national clinical guidelines van Os N, Niessen L W, Bilo H J, Casparie A F, van Hout B A Record Status This is a critical abstract

More information

Smoking decreases the duration of life lived with and without cardiovascular disease: a life course analysis of the Framingham Heart Study

Smoking decreases the duration of life lived with and without cardiovascular disease: a life course analysis of the Framingham Heart Study European Heart Journal (24) 25, 49 45 Clinical research Smoking decreases the duration of life lived with and without cardiovascular disease: a life course analysis of the Framingham Heart Study Abdullah

More information

Northern Tobacco Use Monitoring Survey Northwest Territories Report. Health and Social Services

Northern Tobacco Use Monitoring Survey Northwest Territories Report. Health and Social Services Northern Tobacco Use Monitoring Survey 2004 Northwest Territories Report Health and Social Services 1.0 Introduction The Canadian Tobacco Use Monitoring Survey (CTUMS) was initiated in 1999 to provide

More information

A REPORT ON THE INCIDENCE AND PREVALENCE OF YOUTH TOBACCO USE IN DELAWARE :

A REPORT ON THE INCIDENCE AND PREVALENCE OF YOUTH TOBACCO USE IN DELAWARE : A REPORT ON THE INCIDENCE AND PREVALENCE OF YOUTH TOBACCO USE IN DELAWARE : RESULTS FROM ADMINISTRATION OF THE DELAWARE YOUTH TOBACCO SURVEY IN SPRING 2000 Delaware Health and Social Services Division

More information

Gender Differences in Use of Smoking Cessation Services and Resources: A Real-World Study of Ontario Smokers

Gender Differences in Use of Smoking Cessation Services and Resources: A Real-World Study of Ontario Smokers PROJECT NEWS July 2018 Gender Differences in Use of Smoking Cessation Services and Resources: A Real-World Study of Ontario Smokers Smoking cessation greatly reduces the health burden of tobacco use. 1,2

More information

ISCHEMIC VASCULAR DISEASE (IVD) MEASURES GROUP OVERVIEW

ISCHEMIC VASCULAR DISEASE (IVD) MEASURES GROUP OVERVIEW ISCHEMIC VASCULAR DISEASE (IVD) MEASURES GROUP OVERVIEW 2014 PQRS OPTIONS F MEASURES GROUPS: 2014 PQRS MEASURES IN ISCHEMIC VASCULAR DISEASE (IVD) MEASURES GROUP: #204. Ischemic Vascular Disease (IVD):

More information

Table Of Content. Page 1/7

Table Of Content. Page 1/7 Table Of Content Closing the Gap - Reducing Premature Mortality. Baseline for Monitoring Health Evolution Following Enlargement... 2 Summary... 3 Coordinator, Leader contact and partners... 5 Outputs...

More information

Tobacco dependence: Implications for service provision

Tobacco dependence: Implications for service provision Tobacco dependence: Implications for service provision Andy McEwen, PhD University College London & National Centre for Smoking Cessation and Training (NCSCT) Tuesday 29th January 2013 Cardiff Conflict

More information

Text 1: E-Cigarettes, the solution or another risk factor?

Text 1: E-Cigarettes, the solution or another risk factor? Text 1: E-Cigarettes, the solution or another risk factor? This excerpt is from Medpage Today 'HypeWatch: E-Cigs Best Cessation Tool Ever, Really?' Published: May 20, 2014 A retrospective analysis comparing

More information

Study population The study population comprised a hypothetical cohort of poorly reversible COPD patients with a history of exacerbations.

Study population The study population comprised a hypothetical cohort of poorly reversible COPD patients with a history of exacerbations. Development of an economic model to assess the cost-effectiveness of treatment interventions for chronic obstructive pulmonary disease Spencer M, Briggs A H, Grossman R F, Rance L Record Status This is

More information

Quitline in smoking cessation: a cost-effectiveness analysis Tomson T, Helgason A R, Gilljam H

Quitline in smoking cessation: a cost-effectiveness analysis Tomson T, Helgason A R, Gilljam H Quitline in smoking cessation: a cost-effectiveness analysis Tomson T, Helgason A R, Gilljam H Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion

More information

Smoking Rates and Tobacco Cessation Coverage in Medicaid Expansion

Smoking Rates and Tobacco Cessation Coverage in Medicaid Expansion Smoking Rates and Tobacco Cessation Coverage in Medicaid Expansion On December 8, 2016, State Medicaid Expansion Tobacco Cessation Coverage and Number of Adult Smokers Enrolled in Expansion Coverage United

More information

Modeling the Population Health Effects of Camel Snus with Reduced Risk Information

Modeling the Population Health Effects of Camel Snus with Reduced Risk Information Modeling the Population Health Effects of Camel Snus with Reduced Risk Information Geoffrey Curtin, Ph.D. - RAI Services Company Annette Bachand, Ph.D., Sandra Sulsky, Ph.D. - Ramboll Environ; Saul Shiffman,

More information

A randomized trial comparing two Internetbased smoking cessation programs

A randomized trial comparing two Internetbased smoking cessation programs A randomized trial comparing two Internetbased smoking cessation programs Jean-François ETTER Faculty of Medicine, University of Geneva, Switzerland E-mail: Jean-Francois.Etter@unige.ch Acknowledgements

More information

Crossing Borders: Factors Affecting Differences in Cost-Effectiveness of Smoking Cessation Interventions between European Countriesvhe_

Crossing Borders: Factors Affecting Differences in Cost-Effectiveness of Smoking Cessation Interventions between European Countriesvhe_ Volume 13 Number 2 2010 VALUE IN HEALTH Crossing Borders: Factors Affecting Differences in Cost-Effectiveness of Smoking Cessation Interventions between European Countriesvhe_612 230..241 Pepijn Vemer,

More information

Projections for smoking prevalence in New Zealand: Business-as-usual and with increased tobacco tax

Projections for smoking prevalence in New Zealand: Business-as-usual and with increased tobacco tax 1 Projections for smoking prevalence in New Zealand: Business-as-usual and with increased tobacco tax Nick Wilson (presenter), Frederieke S. van der Deen, Tak Ikeda, Linda Cobiac, Tony Blakely October

More information

Potential effect of salt reduction in processed foods on health 1 3

Potential effect of salt reduction in processed foods on health 1 3 Potential effect of salt reduction in processed foods on health 1 3 Marieke AH Hendriksen, Rudolf T Hoogenveen, Jeljer Hoekstra, Johanna M Geleijnse, Hendriek C Boshuizen, and Joop MA van Raaij ABSTRACT

More information

Name: CQ4 DP1 What actions are needed to address Australia s health priorities?

Name: CQ4 DP1 What actions are needed to address Australia s health priorities? Name: CQ4 DP1 What actions are needed to address Australia s health priorities? health promotion based on the five action areas of the Ottawa Charter levels of responsibility for health promotion the benefits

More information

How Might Medicinal Regulators Evolve in their Expectations for ENDS? David M Graham Chief Impact Officer - NJOY

How Might Medicinal Regulators Evolve in their Expectations for ENDS? David M Graham Chief Impact Officer - NJOY How Might Medicinal Regulators Evolve in their Expectations for ENDS? David M Graham Chief Impact Officer - NJOY 4 Years Ago The Regulation of Nicotine-Containing Products Jeremy Mean 2015 The fact that

More information

Smoking cessation interventions and services

Smoking cessation interventions and services National Institute for Health and Care Excellence Guideline version (Final) Smoking cessation interventions and services [E] Evidence reviews for advice NICE guideline NG92 Evidence reviews FINAL These

More information

Identifying best practice in actions on tobacco smoking to reduce health inequalities

Identifying best practice in actions on tobacco smoking to reduce health inequalities Identifying best practice in actions on tobacco smoking to reduce health inequalities An Matrix Knowledge Report to the Consumers, Health and Food Executive Agency, funded by the Health Programme of the

More information

Quantitative benefit-risk assessment: An analytical framework for a shared understanding of the effects of medicines. Patrick Ryan 21 April 2010

Quantitative benefit-risk assessment: An analytical framework for a shared understanding of the effects of medicines. Patrick Ryan 21 April 2010 Quantitative benefit-risk assessment: An analytical framework for a shared understanding of the effects of medicines Patrick Ryan 21 April 2010 Challenges in understanding the effects of medicines Benefit

More information

Cost-benefit analysis of sustained-release bupropion, nicotine patch, or both for smoking cessation Nielsen K, Fiore M C

Cost-benefit analysis of sustained-release bupropion, nicotine patch, or both for smoking cessation Nielsen K, Fiore M C Cost-benefit analysis of sustained-release bupropion, nicotine patch, or both for smoking cessation Nielsen K, Fiore M C Record Status This is a critical abstract of an economic evaluation that meets the

More information

Changes in Number of Cigarettes Smoked per Day: Cross-Sectional and Birth Cohort Analyses Using NHIS

Changes in Number of Cigarettes Smoked per Day: Cross-Sectional and Birth Cohort Analyses Using NHIS Changes in Number of Cigarettes Smoked per Day: Cross-Sectional and Birth Cohort Analyses Using NHIS David M. Burns, Jacqueline M. Major, Thomas G. Shanks INTRODUCTION Smoking norms and behaviors have

More information

DP Program 2 National Comprehensive Cancer Control Program. Objective Reviewer s Tool March 2017

DP Program 2 National Comprehensive Cancer Control Program. Objective Reviewer s Tool March 2017 DP17-1701 Program 2 National Comprehensive Cancer Control Program Objective Reviewer s Tool March 2017 Approach (0-40 total points) Describes the cancer burden in the applicant s jurisdiction? (5) Clearly

More information

Tobacco Use Screening and Counseling: Technical Report Prepared for the National Commission on Prevention Priorities

Tobacco Use Screening and Counseling: Technical Report Prepared for the National Commission on Prevention Priorities Tobacco Use Screening and Counseling: Technical Report Prepared for the National Commission on Prevention Priorities Version 06.1; last updated May 11, 2006 Prepared by Leif I. Solberg, MD* Michael V.

More information

Brief interventions delivered in GP surgeries to improve quit rates

Brief interventions delivered in GP surgeries to improve quit rates Brief interventions delivered in GP surgeries to improve quit rates Matrix Insight, in collaboration with Imperial College London, Kings College London and Bazian Ltd, were commissioned by Health England

More information

HAMILTON COUNTY DATA PROFILE ADULT CIGARETTE SMOKING. North Country Population Health Improvement Program

HAMILTON COUNTY DATA PROFILE ADULT CIGARETTE SMOKING. North Country Population Health Improvement Program HAMILTON COUNTY DATA PROFILE ADULT CIGARETTE SMOKING North Country Population Health Improvement Program HAMILTON COUNTY DATA PROFILE: ADULT CIGARETTE SMOKING INTRODUCTION The Hamilton County Data Profile

More information

Annex 1: MINDMAP research teams

Annex 1: MINDMAP research teams Annex 1: MINDMAP research teams The Department of Public Health from the Erasmus MC in Rotterdam is a leading centre of public health research both within the Netherlands, and internationally and it is

More information

Is the AAA screening of any value in women?

Is the AAA screening of any value in women? Is the AAA screening of any value in women? A. Karkamanis Vascular Surgeon Dept. of Vascular Surgery Uppsala University SWEDEN Why screening women for AAA? consistently display a much lower AAA prevalence

More information

HPA tobacco control research programme. Tobacco Control Webinar June 2016

HPA tobacco control research programme. Tobacco Control Webinar June 2016 HPA tobacco control research programme Tobacco Control Webinar June 2016 Acknowledgements The work presented today represents significant input from: Hayley Guiney Joanna White Judy Li Holly Trowland Sicily

More information

Save Lives and Save Money

Save Lives and Save Money Tobacco Control Policies & Programs Save Lives and Save Money Matthew L. Myers President, Campaign for Tobacco Free Kids Alliance for Health Reform Luncheon Briefing July 13, 2012 1 We Know How to Reduce

More information

Measuring cancer survival in populations: relative survival vs cancer-specific survival

Measuring cancer survival in populations: relative survival vs cancer-specific survival Int. J. Epidemiol. Advance Access published February 8, 2010 Published by Oxford University Press on behalf of the International Epidemiological Association ß The Author 2010; all rights reserved. International

More information

Nicotine replacement therapy to improve quit rates

Nicotine replacement therapy to improve quit rates Nicotine replacement therapy to improve quit rates Matrix Insight, in collaboration with Imperial College London, Kings College London and Bazian Ltd, were commissioned by Health England to undertake a

More information

Sample Evaluation Plan. Indicator 4.1.1

Sample Evaluation Plan. Indicator 4.1.1 Sample Evaluation Plan Indicator 4.1.1 Number of culturally and linguistically appropriate behavior modification-based tobacco cessation services that are available and well utilized in the community Objective:

More information

Clinical impact and health economic consequences of post-transplant type 2 diabetes mellitus Chilcott J B, Whitby S M, Moore R

Clinical impact and health economic consequences of post-transplant type 2 diabetes mellitus Chilcott J B, Whitby S M, Moore R Clinical impact and health economic consequences of post-transplant type 2 diabetes mellitus Chilcott J B, Whitby S M, Moore R Record Status This is a critical abstract of an economic evaluation that meets

More information

Assessing Access to Smoking Cessation Resources in Rural Populations

Assessing Access to Smoking Cessation Resources in Rural Populations University of Vermont ScholarWorks @ UVM Family Medicine Block Clerkship, Student Projects College of Medicine 2016 Assessing Access to Smoking Cessation Resources in Rural Populations Tristan McKnight

More information

CEASE: A novel electronic patient directed knowledge translation tool to improve smoking cessation in cancer patients

CEASE: A novel electronic patient directed knowledge translation tool to improve smoking cessation in cancer patients CEASE: A novel electronic patient directed knowledge translation tool to improve smoking cessation in cancer patients Meredith Giuliani, Geoffrey Liu, Mihaela Dirlea, Victoria Milne, Peter Selby, David

More information

Progress toward quitting. The cessation environment in New York

Progress toward quitting. The cessation environment in New York Progress toward quitting The cessation environment in New York TCP Vision and Mission Vision: All New Yorkers live in a tobacco free society. Mission: Reduce morbidity and mortality and alleviate social

More information

Colorado s Progress toward Year 2000 Objectives

Colorado s Progress toward Year 2000 Objectives Colorado s Progress toward Year Objectives An update from the Survey Research Unit No. 26 November 1998 Two major roles of Public Health are to reduce preventable death and disability and to enhance quality

More information

A REPORT ON THE INCIDENCE AND PREVALENCE OF YOUTH TOBACCO USE IN DELAWARE

A REPORT ON THE INCIDENCE AND PREVALENCE OF YOUTH TOBACCO USE IN DELAWARE A REPORT ON THE INCIDENCE AND PREVALENCE OF YOUTH TOBACCO USE IN DELAWARE RESULTS FROM THE ADMINISTRATION OF THE DELAWARE YOUTH TOBACCO SURVEY IN SPRING 00 Delaware Health and Social Services Division

More information

RADM Patrick O Carroll, MD, MPH Senior Advisor, Assistant Secretary for Health, US DHSS

RADM Patrick O Carroll, MD, MPH Senior Advisor, Assistant Secretary for Health, US DHSS Ending the Tobacco Epidemic RADM Patrick O Carroll, MD, MPH Senior Advisor, Assistant Secretary for Health, US DHSS Tim McAfee, MD, MPH Senior Medical Officer, Office on Smoking and Health, CDC www.nwcphp.org/hot-topics

More information

The effectiveness of smoking cessation treatments used in the "real world"

The effectiveness of smoking cessation treatments used in the real world Medizinische Fakultät The effectiveness of smoking cessation treatments used in the "real world" Daniel Kotz, PhD 11 March 2015 Heinrich-Heine-University Düsseldorf Maastricht University University College

More information

Setting The setting was a hospital and the community. The economic analysis was carried out in the USA.

Setting The setting was a hospital and the community. The economic analysis was carried out in the USA. Economic model of sustained-release bupropion hydrochloride in health plan and work site smoking-cessation programs Halpern M T, Khan Z M, Young T L, Battista C Record Status This is a critical abstract

More information

Tobacco Reduction as a National & Regional Priority: Issuing a Challenge for Tobacco-Free Campuses. At-a-Glance:

Tobacco Reduction as a National & Regional Priority: Issuing a Challenge for Tobacco-Free Campuses. At-a-Glance: Tobacco Reduction as a National & Regional Priority: Issuing a Challenge for Tobacco-Free Campuses RADM Clara H. Cobb Assistant Surgeon General U.S. Department of Health and Human Services Regional Health

More information

My Background. State of Behavioral Health. State of Behavioral Health. Tailoring the Messages and the Medicines to Optimize Cessation Interventions

My Background. State of Behavioral Health. State of Behavioral Health. Tailoring the Messages and the Medicines to Optimize Cessation Interventions Tailoring the Messages and the Medicines to Optimize Cessation Interventions Stephen S. Michael, MS Director, ASHLine My Background Master s Degree in Rehabilitation Counseling 20+ years developing and

More information

A. Green, C. Sortsø, P.B. Jensen, M. Emneus

A. Green, C. Sortsø, P.B. Jensen, M. Emneus A. Green, C. Sortsø, P.B. Jensen, M. Emneus European Diabetes Epidemiology Group EDEG 2015, Chantilly, April 25-27, 2015 The Diabetes Impact Study 2013 uses all available register information on diabetes

More information